🧠 Valuation Insight: Don’t Let the Scripts Fool You

💊 Pharmacies can post steady revenue—but valuation pitfalls are everywhere.

Common traps:

  • PBM reimbursements below cost
  • Owner is the primary pharmacist
  • No non-compete from departing seller
  • Prescription volume inflated by short-term scripts

📌 Rule of thumb: A buyer without a license can’t step into the seller’s shoes—and value must reflect that.

✅ Normalize cash flow for staffing needs, regulatory limits, and non-transferable goodwill.